Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
FDA
Biotech
Amgen's early-stage obesity asset put on clinical hold by FDA
Amgen didn’t disclose the reason for the hold, but said it doesn't believe the issue is with the drug and will still work to develop the asset.
Darren Incorvaia
Feb 4, 2025 6:13pm
FDA digital director Troy Tazbaz departs the agency
Jan 31, 2025 3:38pm
Takeda axes epilepsy asset after FDA weighs in on data package
Jan 30, 2025 7:19am
FDA clears Imperative Care's largest large-bore stroke catheter
Jan 28, 2025 4:00pm
NIH clarifies how the HHS freeze impacts the division
Jan 27, 2025 5:45pm
FDA's diagnostics CMO named interim agency commissioner
Jan 27, 2025 11:30am